Cargando…

Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?—a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools

BACKGROUND: To date, the risk/benefit balance of lockdown in controlling severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) epidemic is controversial. OBJECTIVE: We aimed to investigate the effectiveness of lockdown on SARS-CoV-2 epidemic progression in nine different countries (New Zealan...

Descripción completa

Detalles Bibliográficos
Autores principales: Mégarbane, Bruno, Bourasset, Fanchon, Scherrmann, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806254/
https://www.ncbi.nlm.nih.gov/pubmed/33442818
http://dx.doi.org/10.1007/s11606-020-06345-5
_version_ 1783636489130737664
author Mégarbane, Bruno
Bourasset, Fanchon
Scherrmann, Jean-Michel
author_facet Mégarbane, Bruno
Bourasset, Fanchon
Scherrmann, Jean-Michel
author_sort Mégarbane, Bruno
collection PubMed
description BACKGROUND: To date, the risk/benefit balance of lockdown in controlling severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) epidemic is controversial. OBJECTIVE: We aimed to investigate the effectiveness of lockdown on SARS-CoV-2 epidemic progression in nine different countries (New Zealand, France, Spain, Germany, the Netherlands, Italy, the UK, Sweden, and the USA). DESIGN: We conducted a cross-country comparative evaluation using a susceptible-infected-recovered (SIR)-based model completed with pharmacokinetic approaches. MAIN MEASURES: The rate of new daily SARS-CoV-2 cases in the nine countries was calculated from the World Health Organization’s published data. Using a SIR-based model, we determined the infection (β) and recovery (γ) rate constants; their corresponding half-lives (t(1/2β) and t(1/2γ)); the basic reproduction numbers (R(0) as β/γ); the rates of susceptible S(t), infected I(t), and recovered R(t) compartments; and the effectiveness of lockdown. Since this approach requires the epidemic termination to build the (I) compartment, we determined S(t) at an early epidemic stage using simple linear regressions. KEY RESULTS: In New Zealand, France, Spain, Germany, the Netherlands, Italy, and the UK, early-onset stay-at-home orders and restrictions followed by gradual deconfinement allowed rapid reduction in SARS-CoV-2-infected individuals (t(1/2β) ≤ 14 days) with R(0) ≤ 1.5 and rapid recovery (t(1/2γ) ≤ 18 days). By contrast, in Sweden (no lockdown) and the USA (heterogeneous state-dependent lockdown followed by abrupt deconfinement scenarios), a prolonged plateau of SARS-CoV-2-infected individuals (terminal t(1/2β) of 23 and 40 days, respectively) with elevated R(0) (4.9 and 4.4, respectively) and non-ending recovery (terminal t(1/2γ) of 112 and 179 days, respectively) was observed. CONCLUSIONS: Early-onset lockdown with gradual deconfinement allowed shortening the SARS-CoV-2 epidemic and reducing contaminations. Lockdown should be considered as an effective public health intervention to halt epidemic progression.
format Online
Article
Text
id pubmed-7806254
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-78062542021-01-14 Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?—a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools Mégarbane, Bruno Bourasset, Fanchon Scherrmann, Jean-Michel J Gen Intern Med Original Research BACKGROUND: To date, the risk/benefit balance of lockdown in controlling severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) epidemic is controversial. OBJECTIVE: We aimed to investigate the effectiveness of lockdown on SARS-CoV-2 epidemic progression in nine different countries (New Zealand, France, Spain, Germany, the Netherlands, Italy, the UK, Sweden, and the USA). DESIGN: We conducted a cross-country comparative evaluation using a susceptible-infected-recovered (SIR)-based model completed with pharmacokinetic approaches. MAIN MEASURES: The rate of new daily SARS-CoV-2 cases in the nine countries was calculated from the World Health Organization’s published data. Using a SIR-based model, we determined the infection (β) and recovery (γ) rate constants; their corresponding half-lives (t(1/2β) and t(1/2γ)); the basic reproduction numbers (R(0) as β/γ); the rates of susceptible S(t), infected I(t), and recovered R(t) compartments; and the effectiveness of lockdown. Since this approach requires the epidemic termination to build the (I) compartment, we determined S(t) at an early epidemic stage using simple linear regressions. KEY RESULTS: In New Zealand, France, Spain, Germany, the Netherlands, Italy, and the UK, early-onset stay-at-home orders and restrictions followed by gradual deconfinement allowed rapid reduction in SARS-CoV-2-infected individuals (t(1/2β) ≤ 14 days) with R(0) ≤ 1.5 and rapid recovery (t(1/2γ) ≤ 18 days). By contrast, in Sweden (no lockdown) and the USA (heterogeneous state-dependent lockdown followed by abrupt deconfinement scenarios), a prolonged plateau of SARS-CoV-2-infected individuals (terminal t(1/2β) of 23 and 40 days, respectively) with elevated R(0) (4.9 and 4.4, respectively) and non-ending recovery (terminal t(1/2γ) of 112 and 179 days, respectively) was observed. CONCLUSIONS: Early-onset lockdown with gradual deconfinement allowed shortening the SARS-CoV-2 epidemic and reducing contaminations. Lockdown should be considered as an effective public health intervention to halt epidemic progression. Springer International Publishing 2021-01-13 2021-03 /pmc/articles/PMC7806254/ /pubmed/33442818 http://dx.doi.org/10.1007/s11606-020-06345-5 Text en © Society of General Internal Medicine 2020
spellingShingle Original Research
Mégarbane, Bruno
Bourasset, Fanchon
Scherrmann, Jean-Michel
Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?—a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools
title Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?—a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools
title_full Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?—a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools
title_fullStr Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?—a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools
title_full_unstemmed Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?—a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools
title_short Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?—a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools
title_sort is lockdown effective in limiting sars-cov-2 epidemic progression?—a cross-country comparative evaluation using epidemiokinetic tools
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806254/
https://www.ncbi.nlm.nih.gov/pubmed/33442818
http://dx.doi.org/10.1007/s11606-020-06345-5
work_keys_str_mv AT megarbanebruno islockdowneffectiveinlimitingsarscov2epidemicprogressionacrosscountrycomparativeevaluationusingepidemiokinetictools
AT bourassetfanchon islockdowneffectiveinlimitingsarscov2epidemicprogressionacrosscountrycomparativeevaluationusingepidemiokinetictools
AT scherrmannjeanmichel islockdowneffectiveinlimitingsarscov2epidemicprogressionacrosscountrycomparativeevaluationusingepidemiokinetictools